{
    "code": "02017359",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02017359",
    "time": "2019-08-23 03:26:55",
    "許可證字號": "衛署藥輸字第017359號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/07\/31",
    "發證日期": "103\/06\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201735901",
    "中文品名": "保利保錠",
    "英文品名": "BOLABOMIN TABLETS",
    "適應症": "緩解發炎及因發炎反應引起之疼痛。",
    "劑型": "116膜衣錠",
    "包裝": "12-1000粒盒裝 12-1000粒瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "DICLOFENAC SODIUM",
    "主製造廠": {
        "申請商名稱": "0605901100  光亨企業有限公司",
        "申請商地址": "新北市汐止區新台五路一段97號26樓之1",
        "主製造廠": "",
        "製造廠名稱": "FJP0389000  TSURUHARA PHARMACEUTICAL CO. LTD."
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808400410",
            "成分名稱": "DICLOFENAC SODIUM",
            "含量描述": "25",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "保利保錠中文仿單-105-12-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017359&Seq=006&Type=9"
        },
        {
            "title": "保利保錠外盒標籤鋁箔-105-12-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017359&Seq=006&Type=8"
        }
    ]
}